miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer

por Zhao, Helong, Wilkie, Tasha, Deol, Yadwinder, Sneh, Amita, Ganju, Akaansha, Basree, Mustafa, Nasser, Mohd W, Ganju, Ramesh K
Publicado 2015

Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer

por Zhao, Helong, Wilkie, Tasha, Deol, Yadwinder, Sneh, Amita, Ganju, Akaansha, Basree, Mustafa, Nasser, Mohd W., Ganju, Ramesh K.
Publicado 2015

MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor

por Martin del Campo, Sara E., Latchana, Nicholas, Levine, Kala M., Grignol, Valerie P., Fairchild, Ene T., Jaime-Ramirez, Alena Cristina, Dao, Thao-Vi, Karpa, Volodymyr I., Carson, Mary, Ganju, Akaansha, Chan, Anthony N., Carson III, William E.
Publicado 2015

Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

por Morgan, Evan, Suresh, Anupama, Ganju, Akaansha, Stover, Daniel G., Wesolowski, Robert, Sardesai, Sagar, Noonan, Anne, Reinbolt, Raquel, VanDeusen, Jeffrey, Williams, Nicole, Cherian, Mathew A., Li, Zaibo, Young, Gregory, Palettas, Marilly, Stephens, Julie, Liu, Joseph, Luff, Amanda, Ramaswamy, Bhuvaneswari, Lustberg, Maryam
Publicado 2020